[go: up one dir, main page]

TNSN99138A1 - Une composition antioxydante, cytostatique et a support energetique qui ameliore l'utilisation metabolique du glucose - Google Patents

Une composition antioxydante, cytostatique et a support energetique qui ameliore l'utilisation metabolique du glucose

Info

Publication number
TNSN99138A1
TNSN99138A1 TNTNSN99138A TNSN99138A TNSN99138A1 TN SN99138 A1 TNSN99138 A1 TN SN99138A1 TN TNSN99138 A TNTNSN99138 A TN TNSN99138A TN SN99138 A TNSN99138 A TN SN99138A TN SN99138 A1 TNSN99138 A1 TN SN99138A1
Authority
TN
Tunisia
Prior art keywords
composition
cytostatic
antioxidant
glucose
improves
Prior art date
Application number
TNTNSN99138A
Other languages
English (en)
Inventor
Cavazza Claudio
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of TNSN99138A1 publication Critical patent/TNSN99138A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

-UNE COMPOSITION POUR LA PREVENTION ET/OU LE TRAITEMENT THERAPEUTIQUE DE DIFFERENTES ALTERATIONS OU ETATS PATHOLOGIQUES INDUITS PAR LA PRESENCE DE RADICAUX A L'ETAT LIBRE. CETTE COMPOSITION PEUT AVOIR LA FORME D'UN SUPPLEMENT DIETETIQUE, D'UN SUPPORT DIETETIQUE OU D'UN MEDICAMENT EFFECTIF. CETTE COMPOSITION AINSI DIVULGUEE COMPREND COMME INGREDIENTS CARACTERISTIQUES ACTIFS L'ACETYL L-CARNITINE ET AU MOINS UN CATECHINE (TEL QUE LE GALLATE D'EPIGALLOCATECHINE) QUI PEUT ETRE EXTRAIT DU THE VERT.
TNTNSN99138A 1998-06-30 1999-06-30 Une composition antioxydante, cytostatique et a support energetique qui ameliore l'utilisation metabolique du glucose TNSN99138A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000433A IT1299197B1 (it) 1998-06-30 1998-06-30 Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.

Publications (1)

Publication Number Publication Date
TNSN99138A1 true TNSN99138A1 (fr) 2005-11-10

Family

ID=11406017

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99138A TNSN99138A1 (fr) 1998-06-30 1999-06-30 Une composition antioxydante, cytostatique et a support energetique qui ameliore l'utilisation metabolique du glucose

Country Status (5)

Country Link
AR (1) AR019737A4 (fr)
AU (1) AU4391199A (fr)
IT (1) IT1299197B1 (fr)
TN (1) TNSN99138A1 (fr)
WO (1) WO2000000183A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
IT1317035B1 (it) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti dal
IT1317036B1 (it) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti da piante
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
JP2005533864A (ja) * 2002-07-26 2005-11-10 ディーエスエム アイピー アセッツ ビー.ブイ. ラクトフェリンを含む組成物
EP1558199A4 (fr) * 2002-10-11 2006-06-28 Creagri Inc Combinaison therapeutique de carnitine et de polyphenols antioxydant
JP2005089384A (ja) * 2003-09-18 2005-04-07 Kao Corp 持久力向上剤
US7205011B2 (en) 2003-11-14 2007-04-17 Board Of Regents, Acting For And On Behalf Of, University Of Arizona Anti-inflammatory activity of a specific turmeric extract
AU2007273955B2 (en) * 2006-06-08 2012-09-06 Mars, Incorporated Composition for improving eye health
AU2007257523B2 (en) * 2006-06-08 2013-04-11 Mars, Incorporated Use of at least one polyphenol for promoting eye health
CN107048383A (zh) 2012-10-04 2017-08-18 雅培制药有限公司 用于增强EGCg对减缓骨骼肌损失的作用的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
AU6482596A (en) * 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases

Also Published As

Publication number Publication date
AR019737A4 (es) 2002-03-13
ITRM980433A1 (it) 1999-12-30
WO2000000183A3 (fr) 2000-06-29
IT1299197B1 (it) 2000-02-29
WO2000000183A2 (fr) 2000-01-06
AU4391199A (en) 2000-01-17
ITRM980433A0 (it) 1998-06-30

Similar Documents

Publication Publication Date Title
TNSN99163A1 (fr) COMPOSITION ANTIOXYDANTE COMPRENANT L'ACETYL-CARNITINE ET L'ACIDE α -LIPOIQUE QUI AMELIORE L'UTILISATION METABOLIQUE DU GLUCOSE
TNSN99132A1 (fr) Une composition pour la prevention et/ou le traitement de l'osteoporose ou des alterations dues au syndrome de menopause
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
TR200003666T2 (tr) Akut bir astım vakasının önlenmesi , tedavisi için formoterol
FR2715582B1 (fr) Microcapsules à paroi de flavonoïde réticulée et compositions en contenant.
CA2339221A1 (fr) Extraits de chrysanteme-matricaire (tanacetum parthenium) utilises contre les troubles inflammatoires
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
MX9800782A (es) Composiciones para la liberacion topica de ingredientes activos.
KR970020098A (ko) 항스트레스 조성물
TNSN99138A1 (fr) Une composition antioxydante, cytostatique et a support energetique qui ameliore l'utilisation metabolique du glucose
NO20012954L (no) Olje-i-vann-emulsjon omfattende et mikronisert biologisk aktivt middel og et passende emulgeringsmiddelsystem
TNSN99135A1 (fr) Composition neuroprotectrice pour la prevention et/ou le traitement des troubles nerveux ou de comportement dus aux etats d'anxiete ou de depression
ATE271392T1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
PT942741E (pt) Composicoes de lectina e suas utilizacoes
BR0011447A (pt) Composição compreendendo esfingomielinase alcalina para aplicação como uma preparação dietética, suplemento alimentar ou produto farmacêutico
TR200200948T2 (tr) L-karnitin türevlerini ve ginkgo biloba özlerini içeren bileşim
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
TNSN99212A1 (fr) Composition antioxydante et preventive contre les anomalies thrombotiques et atherosclerotiques, comportant un carnitine et un flavonoide
CA2343116A1 (fr) Methodes et compositions permettant d'augmenter l'absorption intestinale des lipides
EP4640222A3 (fr) Nouvelle association de gastrodia elata, citicoline, l-acétylcarnitine et vitamine d
ATE239504T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von störungen aufgrund von abnormalen fettstoffmetabolismus, enthaltend l-carnitin und chitosan
TNSN00150A1 (fr) Composition cardioactive comprenant l-carnitine et ses derives et des extraits d'aubepine (crataegus)
IE782550L (en) Cis-(3,3,5) - trimethylcyclohexanol